logo
logo

Leafio partners with Independent Pharmacies Australia; Dr Jean Claude Scicluna joins Helius Therapeutics

Jan 28, 20256 months ago

Contract Type

partnership

AustraliaCannabisBiotechnology

Description

Leafio has formed a strategic partnership with Independent Pharmacies Australia (IPA) to provide advanced technologies, expertise, and support to IPA dispensaries. The partnership aims to optimize operations, enhance patient experience, and provide exclusive discounts to IPA pharmacists. Additionally, Dr. Jean Claude Scicluna has joined Helius Therapeutics as the new medical education manager, bringing extensive experience in medicinal cannabis education from around the world.

Company Information

Company

Leafio; Helius Therapeutics

Location

Australia

About

Leafio is a wholesale distribution arm of Montu, and Helius Therapeutics is a medicinal cannabis firm based in New Zealand.

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months